Kuipers ME - Search Results

1

Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.

Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ. Kuipers ME, et al. Antimicrob Agents Chemother. 1999 Nov;43(11):2635-41. doi: 10.1128/AAC.43.11.2635. Antimicrob Agents Chemother. 1999. PMID: 10543740 Free PMC article.

2

Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis.

Kuipers ME, Heegsma J, Bakker HI, Meijer DK, Swart PJ, Frijlink EW, Eissens AC, de Vries-Hospers HG, van den Berg JJ. Kuipers ME, et al. Drug Deliv. 2002 Jan-Mar;9(1):31-8. doi: 10.1080/107175402753413154. Drug Deliv. 2002. PMID: 11839206

3

Plasma lactoferrin levels are decreased in end-stage AIDS patients.

van der Strate BW, Harmsen MC, The TH, Sprenger HG, de Vries H, Eikelboom MC, Kuipers ME, Meijer DK, Swart PJ. van der Strate BW, et al. Among authors: kuipers me. Viral Immunol. 1999;12(3):197-203. doi: 10.1089/vim.1999.12.197. Viral Immunol. 1999. PMID: 10532648

4

Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida. Impact on the development of buccal preparations of lactoferrin.

Kuipers ME, Beljaars L, Van Beek N, De Vries HG, Heegsma J, Van Den Berg JJ, Meijer DK, Swart PJ. Kuipers ME, et al. APMIS. 2002 Apr;110(4):290-8. doi: 10.1034/j.1600-0463.2002.100403.x. APMIS. 2002. PMID: 12076264

5

Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.

Kuipers ME, Huisman JG, Swart PJ, de Béthune MP, Pauwels R, Schuitemaker H, De Clercq E, Meijer DK. Kuipers ME, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):419-29. doi: 10.1097/00042560-199604150-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8605586

6

Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro.

Swart PJ, Kuipers ME, Smit C, Pauwels R, deBéthune MP, de Clercq E, Meijer DK, Huisman JG. Swart PJ, et al. Among authors: kuipers me. AIDS Res Hum Retroviruses. 1996 Jun 10;12(9):769-75. doi: 10.1089/aid.1996.12.769. AIDS Res Hum Retroviruses. 1996. PMID: 8738428

7

Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice.

Kuipers ME, Swart PJ, Schutten M, Smit C, Proost JH, Osterhaus AD, Meijer DK. Kuipers ME, et al. Antiviral Res. 1997 Jan;33(2):99-108. doi: 10.1016/s0166-3542(96)01005-4. Antiviral Res. 1997. PMID: 9021051

8

The in vitro anti-HIV efficacy of negatively charged human serum albumin is antagonized by heparin.

Swart PJ, Sun CS, Kuipers ME, Asuncion C, Josephs S, Smit C, Meijer DK. Swart PJ, et al. Among authors: kuipers me. AIDS Res Hum Retroviruses. 1997 May 20;13(8):677-83. doi: 10.1089/aid.1997.13.677. AIDS Res Hum Retroviruses. 1997. PMID: 9168236

9

Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.

Kuipers ME, Swart PJ, Witvrouw M, Esté JA, Reymen D, De Clercq E, Meijer DK. Kuipers ME, et al. J Drug Target. 1999;6(5):323-35. doi: 10.3109/10611869908996840. J Drug Target. 1999. PMID: 10342381

10

Charge modification of plasma and milk proteins results in antiviral active compounds.

Swart PJ, Harmsen MC, Kuipers ME, Van Dijk AA, Van Der Strate BW, Van Berkel PH, Nuijens JH, Smit C, Witvrouw M, De Clercq E, de Béthune MP, Pauwels R, Meijer DK. Swart PJ, et al. Among authors: kuipers me. J Pept Sci. 1999 Dec;5(12):563-76. doi: 10.1002/(SICI)1099-1387(199912)5:12<563::AID-PSC226>3.0.CO;2-3. J Pept Sci. 1999. PMID: 10628656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page